Gossamer Bio (GOSS) Price to Sales (2024 - 2026)

Gossamer Bio has reported Price to Sales for 3 years, with the latest figure at 5.54 in Q2 2026.

• On a quarterly basis, Price to Sales fell 77.23% year-over-year to 5.54 in Q2 2026; TTM through Jun 2026 was 0.96, a 86.17% decrease from a year earlier, with the FY2025 full-year figure at 14.94, up 740.53% from the prior year.
• Price to Sales was 5.54 for Q2 2026 at Gossamer Bio, up from 4.57 in the prior quarter.
• The five-year high for Price to Sales was 52.5 in Q4 2025, with the low at 2.12 in Q2 2024.
• Average Price to Sales over 3 years is 22.83, with a median of 23.66 recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Price to Sales surged 1045.6% in 2025, then sank 81.93% in 2026.
• Over 3 years, Price to Sales stood at 21.74 in 2024, then surged by 141.42% to 52.5 in 2025, then slumped by 89.44% to 5.54 in 2026.
• The last three Price to Sales figures came in at 5.54 (Q2 2026), 4.57 (Q1 2026), and 52.5 (Q4 2025), per Business Quant data.